By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
Envoy Medical, Inc. insiders have been one-way buyers this past year: six people put roughly $8.2 million into the stock and nobody sold at market prices.
TAYLOR GLEN A (10% Owner) made the biggest buy, worth around $7.5 million. Notably, at least one C-suite executive was among the buyers.
Looking at the quarterly pattern: No open-market insider buying or selling in the last full quarter. Insiders bought in 2 of the last 7 full quarters. 32 investment managers listed COCH in their latest 13F filings (Q2 2026); more funds bought than sold.
Are insiders buying or selling COCH stock?
In the last 12 months Envoy Medical, Inc. insiders made open-market purchases worth about $8.2 million and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in COCH?
The most recent open-market insider trade in COCH was filed on 2026-02-17.
How many institutions own COCH?
32 investment managers reported holding COCH in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded COCH?
No congressional trades in COCH were reported in the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).